CAPTRUST Financial Advisors
DCPH

CAPTRUST Financial Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

CAPTRUST Financial Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,464
Closed -$266K – 2721
2023
Q4 		$266K Buy
+16,464
New +$210K ﹤0.01% 2194
2022
Q3 		– Sell
-1,039
Closed -$14K – 4296
2022
Q2 		$14K Buy
1,039
+267
+35% +$2.95K ﹤0.01% 3581
2022
Q1 		$7K Sell
772
-396
-34% -$3.37K ﹤0.01% 4013
2021
Q4 		$11K Buy
1,168
+388
+50% +$7.3K ﹤0.01% 3674
2021
Q3 		$27K Buy
780
+334
+75% +$10.7K ﹤0.01% 2978
2021
Q2 		$16K Buy
446
+5
+1% +$194 ﹤0.01% 3282
2021
Q1 		$20K Buy
+441
New +$20.5K ﹤0.01% 3012

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

CAPTRUST Financial Advisors's DCPH Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 16,464 shares — an estimated $266K sold.

CAPTRUST Financial Advisors first reported a position in DCPH in Q1 2021 and held it in 7 quarters. The position peaked at $266K in Q4 2023. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 16,464 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $266K.
  • CAPTRUST Financial Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $266K in Q4 2023.
  • 177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.